Interleukin-1 Blockade in Recently Decompensated Heart Failure

NCT01936909 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Heart Failure

Interventions

DRUG: Anakinra (weeks 1-2)
DRUG: Anakinra (weeks 3-12)
DRUG: Placebo

Sponsor

Virginia Commonwealth University

Collaborators

[object Object]